Fibronostics

Recent Finacing

Series A

Recent Raise

$8M

Fibronostics is a diagnostics company that develops AI-driven, non-invasive blood tests and a cloud platform to stage liver lesions (LIVERFASt), monitor kidney and lung disease, and integrate with providers.